Jiehua Zhou

9.7k total citations · 2 hit papers
86 papers, 7.5k citations indexed

About

Jiehua Zhou is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Jiehua Zhou has authored 86 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 14 papers in Virology and 14 papers in Immunology. Recurrent topics in Jiehua Zhou's work include RNA Interference and Gene Delivery (47 papers), Advanced biosensing and bioanalysis techniques (45 papers) and HIV Research and Treatment (14 papers). Jiehua Zhou is often cited by papers focused on RNA Interference and Gene Delivery (47 papers), Advanced biosensing and bioanalysis techniques (45 papers) and HIV Research and Treatment (14 papers). Jiehua Zhou collaborates with scholars based in United States, China and France. Jiehua Zhou's co-authors include John J. Rossi, N. Minh, Arthur L. da Cunha, Haitang Li, Ling Peng, John Burnett, Piotr Swiderski, Ramesh Akkina, C. Preston Neff and Jane Zhang and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jiehua Zhou

84 papers receiving 7.3k citations

Hit Papers

Aptamers as targeted therapeutics: current ... 2006 2026 2012 2019 2016 2006 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiehua Zhou United States 37 5.0k 1.3k 1.2k 1.1k 657 86 7.5k
Takashi Morimoto Japan 30 2.8k 0.6× 262 0.2× 207 0.2× 442 0.4× 336 0.5× 192 5.7k
Richard M. Levenson United States 29 3.1k 0.6× 126 0.1× 173 0.1× 2.4k 2.3× 305 0.5× 110 7.5k
Fan Yuan United States 47 5.0k 1.0× 85 0.1× 152 0.1× 4.3k 4.0× 1.8k 2.7× 149 11.4k
Anne L. Plant United States 37 2.4k 0.5× 133 0.1× 90 0.1× 1.3k 1.2× 130 0.2× 108 4.5k
David A. Steele Australia 27 417 0.1× 200 0.2× 1.9k 1.6× 502 0.5× 61 0.1× 79 4.3k
Shantanu Singh United States 27 1.7k 0.3× 615 0.5× 494 0.4× 456 0.4× 110 0.2× 79 3.8k
Savaş Tay United States 31 1.5k 0.3× 248 0.2× 45 0.0× 1.4k 1.3× 382 0.6× 74 3.8k
Hiroshi Kikuchi Japan 28 1.1k 0.2× 120 0.1× 57 0.0× 366 0.3× 112 0.2× 180 3.0k
Michael A. Teitell United States 58 6.0k 1.2× 90 0.1× 114 0.1× 1.7k 1.6× 1.4k 2.2× 197 10.6k
Hyungsoon Im United States 40 4.5k 0.9× 63 0.0× 43 0.0× 4.3k 4.0× 1.3k 2.0× 94 8.4k

Countries citing papers authored by Jiehua Zhou

Since Specialization
Citations

This map shows the geographic impact of Jiehua Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiehua Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiehua Zhou more than expected).

Fields of papers citing papers by Jiehua Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiehua Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiehua Zhou. The network helps show where Jiehua Zhou may publish in the future.

Co-authorship network of co-authors of Jiehua Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jiehua Zhou. A scholar is included among the top collaborators of Jiehua Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiehua Zhou. Jiehua Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lam, Kentson, Fanny Zhou, Mary Jean Sunshine, et al.. (2025). The proteostasis network is a therapeutic target in acute myeloid leukemia. Blood. 147(5). 557–572.
2.
Herrera, Alberto, Jiehua Zhou, Min-Sun Song, & John J. Rossi. (2023). Evolution of Cell-Type-Specific RNA Aptamers via Live Cell-Based SELEX. Methods in molecular biology. 2666. 317–346. 3 indexed citations
3.
Johnson, D. T., Dinghai Zheng, Ruijia Wang, et al.. (2021). Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemia. Blood. 139(3). 424–438. 15 indexed citations
4.
Chen, Jiaxuan, Aleksandra Ellert‐Miklaszewska, Stefano Garofalo, et al.. (2020). Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells. Nature Protocols. 16(1). 327–351. 43 indexed citations
5.
Azar, Sasha R., Shannan L. Rossi, Sherry L. Haller, et al.. (2018). ZIKV Demonstrates Minimal Pathologic Effects and Mosquito Infectivity in Viremic Cynomolgus Macaques. Viruses. 10(11). 661–661. 12 indexed citations
6.
Shima, Takahiro, Sayuri Miyauchi, D. T. Johnson, et al.. (2017). CPSF1 Regulates AML1-ETO Fusion Gene Polyadenylation and Stability in t(8;21) Acute Myelogenous Leukemia. Blood. 130. 2498–2498. 2 indexed citations
7.
Zhou, Jiehua & John J. Rossi. (2016). Aptamers as targeted therapeutics: current potential and challenges. Nature Reviews Drug Discovery. 16(3). 181–202. 1654 indexed citations breakdown →
8.
Takáhashi, Mayumí, Xiwei Wu, Michelle Ho, et al.. (2016). High throughput sequencing analysis of RNA libraries reveals the influences of initial library and PCR methods on SELEX efficiency. Scientific Reports. 6(1). 33697–33697. 77 indexed citations
9.
Zhou, Jiehua, Haitang Li, Marc S. Weinberg, et al.. (2015). Cell-Specific RNA Aptamer against Human CCR5 Specifically Targets HIV-1 Susceptible Cells and Inhibits HIV-1 Infectivity. Chemistry & Biology. 22(3). 379–390. 68 indexed citations
10.
Nechaev, Sergey, Chan Gao, Dayson Moreira, et al.. (2013). Intracellular processing of immunostimulatory CpG–siRNA: Toll-like receptor 9 facilitates siRNA dicing and endosomal escape. Journal of Controlled Release. 170(3). 307–315. 42 indexed citations
11.
Zhou, Jiehua, C. Preston Neff, Piotr Swiderski, et al.. (2012). Functional In Vivo Delivery of Multiplexed Anti-HIV-1 siRNAs via a Chemically Synthesized Aptamer With a Sticky Bridge. Molecular Therapy. 21(1). 192–200. 101 indexed citations
12.
Zhou, Jiehua, et al.. (2011). Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery. Journal of Visualized Experiments. 28 indexed citations
13.
Zhou, Jiehua & John J. Rossi. (2010). Aptamer-targeted cell-specific RNA interference. PubMed. 1(1). 4–4. 104 indexed citations
14.
Cunha, Arthur L. da, Jiehua Zhou, & N. Minh. (2006). The Nonsubsampled Contourlet Transform: Theory, Design, and Applications. IEEE Transactions on Image Processing. 15(10). 3089–3101. 1494 indexed citations breakdown →
15.
Zhou, Jiehua, Fanqi Qu, Mu Xiao, et al.. (2006). Cooperative binding and self-assembling behavior of cationic low molecular-weight dendrons with RNA molecules. Organic & Biomolecular Chemistry. 4(3). 581–581. 15 indexed citations
16.
Bashey, Asad, Bridget Medina, Jiehua Zhou, et al.. (2005). Phase I study of a neutralizing monoclonal anti-CTLA4 antibody (MDX-010) in patients with relapse of malignancy after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 11(2). 5–5. 2 indexed citations
17.
Zhou, Jiehua, Jian Chen, Michael Mokotoff, & Edward D. Ball. (2004). Targeting gastrin-releasing peptide receptors for cancer treatment. Anti-Cancer Drugs. 15(10). 921–927. 29 indexed citations
18.
Chen, Jian, Jiehua Zhou, & Edward D. Ball. (2001). Characterization of a New Monoclonal Antibody 6G7 That Recognizes a Unique Antigen on Myeloid and Lymphoid Cells. Journal of Hematotherapy & Stem Cell Research. 10(2). 237–246. 1 indexed citations
20.
Mills, John W., Jiehua Zhou, Lisa Cardoza, & Vergil H. Ferm. (1992). Zinc alters actin filaments in Madin-Darby canine kidney cells. Toxicology and Applied Pharmacology. 116(1). 92–100. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026